Αρχική World News March is Colon Cancer Awareness Month

March is Colon Cancer Awareness Month

I am writing this blog for Colon Cancer Awareness month which is this month, March. March has always been one of my favorite months because of March Madness (NCAA basketball tournament). It is also the month when in 2000 then President Bill Clinton signed a White House Proclamation officially designating March as Colon Cancer Awareness month.

About a year ago, a friend of mine who just turned fifty went for her screening colonoscopy and was found to have an early stage colon cancer requiring surgery. She was understandably upset when she heard the word CANCER but was relieved in the end that she had her colon cancer screening and did not delay which could have led to a different outcome. She, along with my patients, (I am a Gastrointestinal Oncology Nurse Practitioner) inspired me to proceed with my first colonoscopy last year. The American Cancer Society (ACS) changed their recommendation to start colon cancer screening at age 45 in 2018 which had previously been to start at age 50.  The ACS made changes because data showed there was a rising incidence of colorectal cancer being diagnosed in younger and middle-aged patients. A sessile serrated adenoma was found when my colonoscopy was done. This type of polyp is not cancerous but can be pre-cancerous. This type of polyp has an increased risk of developing into a colon cancer if not addressed early. With this being identified I had a repeat colonoscopy this year and no polyps were seen. My gastroenterologist suggested a repeat colonoscopy in two years.   Colon cancer screening presents concerns for many patients that are reported as: unpleasantness of the prep, financial costs, time away from work/limit time to complete the prep, lack of transportation to appointments and now COVID concerns.  Colorectal cancer screening should not put off until the pandemic is over.  I try to reassure my patients when they are due for their colonoscopy screening as part of their surveillance after their colon cancer treatment.

For patients who do not have a history of colon cancer there are a few options for colon cancer screening. Colonoscopy is the preferred and gold standard for testing. Other tests include: flexible sigmoidoscopy, CT colonography, FIT (fecal immunochemical test), High-sensitivity Guaiac based Fecal Occult Blood Test (HSgFOBT), Multi-target Stool DNA Test (MT-sDNA). Each of these tests have pros and cons as any testing does.  You should discuss the options and what is best for you with your primary care provider.

There are few things I would recommend that you ask your primary care provider when discussing colon cancer screening:

  • If you are 45 and older ask your Primary Care Provider (PCP) if they recommend you schedule your screening colonoscopy.
  • If you are concerned about a colonoscopy, ask your PCP what are other options for colon cancer screening and what are the pros/cons of that type of testing versus a colonoscopy?
  • What do I need to do to prepare for the test?  
  • What should I expect during the test and how long does it last?
  • How long does it take to get the test results?
  • What happens if an abnormality is identified?
  • What are things I can do to prevent developing colon cancer?

I strongly recommend commitment to colon cancer screening as it can decrease the deaths related to colon cancer.  Screening is most effective when it is done! So get to it !

Liz Dunphy, DNP, CRNP is a gastrointestinal (GI) oncology nurse practitioner at the Abramson Cancer Center at Penn Presbyterian Medical Center and teaches at the University of Pennsylvania School of Nursing in the Adult Oncology Specialty Minor/Post Masters Certificate Program. Liz works with two oncologists in treating patients with various GI cancers, educating patients about their diagnosis and treatment, managing side effects related to treatment and cancer, implement survivorship and surveillance care plan and help patients and their families navigate end of life care.



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Puppy That Was Born Dead Becomes Therapy Dog for Cancer Patient

This story has been shared as part of the Fur Fam Story Contest. You can submit your own tale through December 5th. Voting will...

ESMO Immuno-Oncology Congress 2021, Geneva, Switzerland, 8-11 December

LUGANO, Switzerland – The ESMO Immuno-Oncology Congress 2021, the European platform dedicated to the development and use of immunotherapies for cancer treatment, will be held...

FDA Approves Sirolimus Protein-Bound Particles for Malignant Perivascular Epithelioid Cell Tumour

On 22 November 2021, the US Food and Drug Administration (FDA) approved sirolimus protein-bound particles for injectable suspension (albumin-bound) (Fyarro, Aadi Bioscience, Inc.) for...

Targeted drug recommended to treat some advanced lung cancer patients

Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer. Non small cell lung cancer cells. The National Institute...

Withdrawal of Application to Change the EU Marketing Authorisation for Cervarix

The European Medicines Agency (EMA) announced on 12 November 2021 that GlaxoSmithKline Biologicals SA withdrew its application to use Cervarix (human papillomavirus vaccine ...

Robin Williams Required Film Companies He Worked With To Hire Homeless People

It’s been years since his passing, but the world still feels the loss of Robin Williams. Not only was he an extremely talented and funny...